Alpinia zerumbet leaf extract attenuates cardiovascular remodeling in 2K1C renovascular hypertension: Association with AT1 receptor and redox-inflammatory responses.
文献摘要
Renovascular hypertension involves persistent activation of the renin-angiotensin-aldosterone system, oxidative stress, inflammation, and cardiovascular remodeling. Alpinia zerumbet leaf extract (ALE) is a polyphenol-rich preparation with known antihypertensive properties. This study investigated the effects of chronic ALE treatment on cardiovascular remodeling in the two-kidney, one-clip (2K1C) model of renovascular hypertension. Male Wistar rats (45 days old; n = 11 per group) were allocated into four groups: Sham, Sham + ALE, 2K1C, and 2K1C + ALE. Animals were subjected to 2K1C surgery or laparotomy (Sham) and received ALE (50 mg/kg/day in drinking water) or vehicle for seven weeks. Blood pressure was monitored throughout the protocol, and vascular reactivity was evaluated in the mesenteric arterial bed. Histological and immunohistochemical analyses assessed structural remodeling, cardiomyocyte cross-sectional area (CSA), fibrosis, and AT1 receptor, TGF-β, and MMP-2 immunostaining in the aorta and heart. Cardiovascular oxidative damage, antioxidant defenses, inflammatory cytokines, nitrite levels, and plasma angiotensin II concentrations were also evaluated. ALE significantly attenuated the rise in systolic, diastolic, and mean blood pressure in 2K1C rats, despite not improving endothelial dysfunction in the mesenteric arterial bed. Treatment prevented increased AT1 receptor immunostaining in the aorta and heart without altering plasma angiotensin II levels. Furthermore, ALE partially reduced aortic hypertrophy, prevented cardiac concentric remodeling, fibrosis, and cardiomyocyte CSA, and reduced TGF-β and MMP-2 immunostaining in both tissues. In addition, ALE reduced lipid peroxidation and inflammatory cytokine levels while restoring antioxidant defenses in the plasma and cardiovascular tissues. ALE attenuates cardiovascular remodeling in renovascular hypertension, associated with reduced AT1 receptor expression and redox-inflammatory responses.